nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—SCN10A—peripheral nervous system—Parkinson's disease	0.0429	0.258	CbGeAlD
Levobupivacaine—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0382	0.0521	CbGpPWpGaD
Levobupivacaine—SCN10A—nerve—Parkinson's disease	0.0335	0.201	CbGeAlD
Levobupivacaine—SCN4A—L1CAM interactions—DLG1—Parkinson's disease	0.0289	0.0393	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—DLG1—Parkinson's disease	0.0278	0.0379	CbGpPWpGaD
Levobupivacaine—Ranolazine—CYP2D6—Parkinson's disease	0.0267	0.266	CrCbGaD
Levobupivacaine—Bupivacaine—CYP2D6—Parkinson's disease	0.0262	0.261	CrCbGaD
Levobupivacaine—Ropivacaine—CYP2D6—Parkinson's disease	0.0211	0.211	CrCbGaD
Levobupivacaine—SCN4A—Axon guidance—NRTN—Parkinson's disease	0.0175	0.0238	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—NRTN—Parkinson's disease	0.0169	0.023	CbGpPWpGaD
Levobupivacaine—Lidocaine—CYP2D6—Parkinson's disease	0.0153	0.153	CrCbGaD
Levobupivacaine—SCN10A—forebrain—Parkinson's disease	0.0139	0.0835	CbGeAlD
Levobupivacaine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0138	0.0188	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0138	0.0188	CbGpPWpGaD
Levobupivacaine—SCN4A—L1CAM interactions—HSPA8—Parkinson's disease	0.0135	0.0184	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—HSPA8—Parkinson's disease	0.013	0.0177	CbGpPWpGaD
Levobupivacaine—SCN4A—L1CAM interactions—DLG4—Parkinson's disease	0.0127	0.0173	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NRTN—Parkinson's disease	0.0125	0.017	CbGpPWpGaD
Levobupivacaine—SCN10A—L1CAM interactions—DLG4—Parkinson's disease	0.0122	0.0166	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NRTN—Parkinson's disease	0.012	0.0164	CbGpPWpGaD
Levobupivacaine—CYP1A2—Methylation—COMT—Parkinson's disease	0.0113	0.0154	CbGpPWpGaD
Levobupivacaine—Lidocaine—ABCB1—Parkinson's disease	0.0109	0.109	CrCbGaD
Levobupivacaine—SCN4A—Axon guidance—DLG1—Parkinson's disease	0.0109	0.0149	CbGpPWpGaD
Levobupivacaine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0106	0.0145	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—DLG1—Parkinson's disease	0.0105	0.0143	CbGpPWpGaD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.0103	0.014	CbGpPWpGaD
Levobupivacaine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00985	0.0134	CbGpPWpGaD
Levobupivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00939	0.0128	CbGpPWpGaD
Levobupivacaine—SCN4A—head—Parkinson's disease	0.0093	0.056	CbGeAlD
Levobupivacaine—SCN10A—spinal cord—Parkinson's disease	0.00893	0.0538	CbGeAlD
Levobupivacaine—SCN4A—nervous system—Parkinson's disease	0.00882	0.0531	CbGeAlD
Levobupivacaine—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.00859	0.0117	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—GDNF—Parkinson's disease	0.00854	0.0116	CbGpPWpGaD
Levobupivacaine—SCN4A—central nervous system—Parkinson's disease	0.00849	0.0511	CbGeAlD
Levobupivacaine—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.00845	0.0115	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00826	0.0113	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—GDNF—Parkinson's disease	0.00823	0.0112	CbGpPWpGaD
Levobupivacaine—SCN10A—head—Parkinson's disease	0.00794	0.0478	CbGeAlD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00792	0.0108	CbGpPWpGaD
Levobupivacaine—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.00785	0.0107	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—DLG1—Parkinson's disease	0.00779	0.0106	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00755	0.0103	CbGpPWpGaD
Levobupivacaine—SCN10A—nervous system—Parkinson's disease	0.00752	0.0453	CbGeAlD
Levobupivacaine—SCN10A—Developmental Biology—DLG1—Parkinson's disease	0.00751	0.0102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00724	0.00987	CbGpPWpGaD
Levobupivacaine—SCN10A—central nervous system—Parkinson's disease	0.00724	0.0436	CbGeAlD
Levobupivacaine—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00708	0.00965	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00705	0.00961	CbGpPWpGaD
Levobupivacaine—SCN4A—brain—Parkinson's disease	0.00674	0.0406	CbGeAlD
Levobupivacaine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00663	0.00903	CbGpPWpGaD
Levobupivacaine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00652	0.00888	CbGpPWpGaD
Levobupivacaine—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00647	0.00882	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00638	0.00869	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00637	0.00868	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GDNF—Parkinson's disease	0.00609	0.0083	CbGpPWpGaD
Levobupivacaine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00606	0.00826	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00593	0.00809	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GDNF—Parkinson's disease	0.00587	0.00801	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00583	0.00794	CbGpPWpGaD
Levobupivacaine—SCN10A—brain—Parkinson's disease	0.00575	0.0346	CbGeAlD
Levobupivacaine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00546	0.00745	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00544	0.00741	CbGpPWpGaD
Levobupivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00539	0.00734	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00514	0.007	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—HSPA8—Parkinson's disease	0.0051	0.00695	CbGpPWpGaD
Levobupivacaine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.005	0.00681	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—HSPA8—Parkinson's disease	0.00492	0.0067	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.0048	0.00654	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—DLG4—Parkinson's disease	0.00479	0.00652	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—GRIN2B—Parkinson's disease	0.00468	0.00637	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—DLG4—Parkinson's disease	0.00461	0.00629	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00458	0.00624	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—GRIN2B—Parkinson's disease	0.00451	0.00615	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00447	0.0061	CbGpPWpGaD
Levobupivacaine—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00403	0.0055	CbGpPWpGaD
Levobupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00401	0.00546	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00399	0.00543	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00399	0.00543	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00396	0.0054	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00396	0.0054	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00389	0.0053	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—ABL1—Parkinson's disease	0.00381	0.0052	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—ABL1—Parkinson's disease	0.00368	0.00501	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—HSPA8—Parkinson's disease	0.00364	0.00496	CbGpPWpGaD
Levobupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00364	0.00496	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00357	0.00486	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00352	0.00479	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—HSPA8—Parkinson's disease	0.00351	0.00478	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—DLG4—Parkinson's disease	0.00342	0.00465	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.00334	0.00455	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.00329	0.00449	CbGpPWpGaD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00326	0.00444	CbGpPWpGaD
Levobupivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00325	0.00443	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.00322	0.00439	CbGpPWpGaD
Levobupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00322	0.00439	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00311	0.00424	CbGpPWpGaD
Levobupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00309	0.00422	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.003	0.00409	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00289	0.00394	CbGpPWpGaD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00275	0.00375	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00274	0.00373	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.00272	0.00371	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00272	0.0037	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00264	0.0036	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.00262	0.00358	CbGpPWpGaD
Levobupivacaine—CYP3A4—nervous system—Parkinson's disease	0.00261	0.0157	CbGeAlD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00252	0.00343	CbGpPWpGaD
Levobupivacaine—CYP3A4—central nervous system—Parkinson's disease	0.00251	0.0151	CbGeAlD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00248	0.00338	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00232	0.00316	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00229	0.00312	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00223	0.00304	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00217	0.00296	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00207	0.00282	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00204	0.00278	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00199	0.00271	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00198	0.0027	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00182	0.00248	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—INS—Parkinson's disease	0.0018	0.00245	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00179	0.00244	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00176	0.0024	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—INS—Parkinson's disease	0.00173	0.00236	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00168	0.00229	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.0016	0.00218	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00159	0.00217	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00154	0.00209	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00151	0.00206	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.0014	0.00191	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00138	0.00189	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00128	0.00175	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00118	0.00161	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00117	0.00159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.00116	0.00159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00116	0.00159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00116	0.00159	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00116	0.00158	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.00116	0.00157	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00115	0.00156	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00114	0.00156	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—Parkinson's disease	0.0011	0.0015	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00108	0.00148	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00107	0.00146	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.00106	0.00145	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—IL6—Parkinson's disease	0.00106	0.00145	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00105	0.00143	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—TNF—Parkinson's disease	0.000974	0.00133	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—TNF—Parkinson's disease	0.000939	0.00128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000898	0.00122	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000894	0.00122	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000892	0.00122	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000886	0.00121	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000881	0.0012	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000821	0.00112	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00081	0.0011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000801	0.00109	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—Parkinson's disease	0.000786	0.00107	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—Parkinson's disease	0.000758	0.00103	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000754	0.00103	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000754	0.00103	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000709	0.000967	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000709	0.000967	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000672	0.000916	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000642	0.000874	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000582	0.000794	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000582	0.000794	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000579	0.000789	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000572	0.000779	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000572	0.000779	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000572	0.000779	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000547	0.000746	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000547	0.000746	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000519	0.000707	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000495	0.000675	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000441	0.000601	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000441	0.000601	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000441	0.000601	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DDC—Parkinson's disease	0.00042	0.000572	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000396	0.00054	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000391	0.000533	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000357	0.000486	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000353	0.000481	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000336	0.000458	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000324	0.000441	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000306	0.000417	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000275	0.000375	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000273	0.000372	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000263	0.000358	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000258	0.000351	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.00024	0.000327	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000237	0.000324	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TH—Parkinson's disease	0.000234	0.000319	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000225	0.000306	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000203	0.000276	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000199	0.000271	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000199	0.000271	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.000198	0.00027	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.000198	0.000269	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.000195	0.000266	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	0.000187	0.000255	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000185	0.000253	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000183	0.00025	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	0.000182	0.000248	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TH—Parkinson's disease	0.000181	0.000246	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GPX1—Parkinson's disease	0.000174	0.000238	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000173	0.000236	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	0.000161	0.000219	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000154	0.000209	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000153	0.000208	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000152	0.000208	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000151	0.000205	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOE—Parkinson's disease	0.00015	0.000204	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000145	0.000197	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.00014	0.000191	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000134	0.000183	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INS—Parkinson's disease	0.000128	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000124	0.000169	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOE—Parkinson's disease	0.000116	0.000157	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INS—Parkinson's disease	9.87e-05	0.000135	CbGpPWpGaD
